Bristol-Myers Squibb ROA 2006-2018 | BMY

Current and historical return on assets (ROA) values for Bristol-Myers Squibb (BMY) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Bristol-Myers Squibb ROA for the three months ending September 30, 2018 was 18.33%.
Bristol-Myers Squibb ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $1.43B $33.73B 4.31%
2018-06-30 $0.38B $32.64B 1.13%
2018-03-31 $0.92B $33.08B 2.74%
2017-12-31 $1.01B $33.55B 3.01%
2017-09-30 $4.23B $33.98B 12.62%
2017-06-30 $4.59B $33.41B 13.71%
2017-03-31 $4.84B $32.94B 14.52%
2016-12-31 $4.46B $33.71B 13.49%
2016-09-30 $3.37B $33.73B 10.34%
2016-06-30 $2.87B $32.83B 8.95%
2016-03-31 $1.57B $31.89B 4.94%
2015-12-31 $1.57B $31.75B 4.85%
2015-09-30 $1.78B $31.78B 5.42%
2015-06-30 $1.79B $31.95B 5.39%
2015-03-31 $2.25B $33.58B 6.71%
2014-12-31 $2.00B $33.75B 5.98%
2014-09-30 $2.72B $33.45B 7.82%
2014-06-30 $2.69B $33.50B 7.55%
2014-03-31 $2.89B $33.42B 7.97%
2013-12-31 $2.56B $38.59B 6.95%
2013-09-30 $2.76B $36.80B 7.62%
2013-06-30 $1.36B $36.25B 3.77%
2013-03-31 $1.47B $35.96B 4.20%
2012-12-31 $1.96B $35.90B 5.76%
2012-09-30 $1.89B $36.04B 5.67%
2012-06-30 $3.56B $31.67B 11.04%
2012-03-31 $3.82B $32.41B 11.82%
2011-12-31 $3.70B $32.97B 11.60%
2011-09-30 $3.32B $32.01B 10.56%
2011-06-30 $3.30B $31.83B 10.52%
2011-03-31 $3.33B $30.85B 10.67%
2010-12-31 $3.09B $31.08B 9.91%
2010-09-30 $10.63B $31.89B 34.09%
2010-06-30 $10.64B $31.05B 34.40%
2010-03-31 $10.70B $30.75B 34.93%
2009-12-31 $10.59B $31.01B 34.89%
2009-09-30 $3.83B $30.95B 12.78%
2009-06-30 $5.44B $29.81B 18.54%
2009-03-31 $5.22B $29.69B 18.06%
2008-12-31 $5.25B $29.49B 18.68%
2008-09-30 $3.91B $28.48B 14.39%
2008-06-30 $2.19B $28.06B 8.25%
2008-03-31 $2.14B $26.33B 8.10%
2007-12-31 $2.17B $25.93B 8.22%
2007-09-30 $2.12B $26.10B 8.08%
2007-06-30 $1.60B $27.18B 6.03%
2007-03-31 $1.56B $26.09B 5.87%
2006-12-31 $1.59B $25.58B 5.89%
2006-09-30 $2.22B $27.22B 8.05%
2006-06-30 $2.84B $27.40B 10.47%
2006-03-31 $3.18B $27.46B 11.95%
2005-12-31 $3.00B $28.14B 11.17%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $87.290B $20.776B
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $396.345B 18.58
Pfizer (PFE) United States $262.998B 14.83
Merck (MRK) United States $205.854B 17.84
Novartis AG (NVS) Switzerland $204.655B 17.49
AbbVie (ABBV) United States $134.597B 11.95
Eli Lilly (LLY) United States $122.680B 21.57
Sanofi (SNY) France $112.713B 13.96
Novo Nordisk (NVO) Denmark $111.107B 18.04
AstraZeneca (AZN) United Kingdom $103.342B 12.83
GlaxoSmithKline (GSK) United Kingdom $101.256B 13.61